Expected earnings - Prothena Corporation plc
Source: US Earnings Reports
Prothena Corporation plc (PRTA) is expected to report $-1.11 for Q2 2025
Prothena Corporation plc
NASDAQ: PRTA
PRTA Trading
-1.3% G/L:
$9.11 Last:
210,412 Volume:
$9.40 Open:
PRTA Latest News
March 09, 2026 04:05:00 pm
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
PRTA Stock Data
$486,084,737
38,757,587
1.22%
55
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 2
